RS Research

📍 Istanbul, Turkey🗓 Founded 2015👥 18 employees💰 Last funded Dec 2021
Biotechnology Research🌐 rsresearch.net
Website LinkedIn
RS Research is a clinical stage biotechnology start-up discovering and developing smart nanomedicines. based on innovative drug delivery platform Sagitta® for targeted chemotherapy. Bringing together the powers of science and industry, we have developed a drug delivery technology that will help patients fighting against cancer with superior therapeutic index, “a Cure With a Smile”. Our proprietary drug delivery platform SagittaTM allows designing targeted drug candidates for different indications, which yields into development of our current own portfolio as well as an outstanding co-development potential.
2
Total investors
1
Early stage
0
Mid stage
1
Late stage
2015
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Turkey
2
Frequently asked questions
Who invested in RS Research?
RS Research has 2 investors on record on gritt.io, including 1 early-stage backers and 1 late-stage investors.
When did RS Research last raise funding?
The most recent investment in RS Research recorded on gritt.io was in December 2021.
When was RS Research founded?
RS Research was founded in 2015.
What industry is RS Research in?
RS Research operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is RS Research based?
RS Research is headquartered in Istanbul, Turkey.